Gyre Therapeutics (GYRE) Shareholder's Equity (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.19% |
| Dec 31, 2025 | 4.03% |
| Sep 30, 2025 | -21.26% |
| Jun 30, 2025 | 24.10% |
| Mar 31, 2025 | 6.00% |
| Dec 31, 2024 | -0.07% |
| Sep 30, 2024 | 5.49% |
| Jun 30, 2024 | 5.15% |
| Mar 31, 2024 | 536.40% |
| Dec 31, 2023 | -83.65% |
| Sep 30, 2023 | 10.13% |
| Jun 30, 2023 | 0.18% |
| Mar 31, 2023 | 7.08% |
| Dec 31, 2022 | 145.85% |
| Sep 30, 2022 | -62.85% |
| Jun 30, 2022 | 191.91% |
| Mar 31, 2022 | -54.45% |
| Dec 31, 2021 | -2.09% |
| Sep 30, 2021 | -28.68% |
| Jun 30, 2021 | -18.18% |
| Mar 31, 2021 | 36.83% |
| Dec 31, 2020 | -19.13% |
| Sep 30, 2020 | -13.68% |
| Jun 30, 2020 | 11.73% |
| Mar 31, 2020 | 42.71% |
| Dec 31, 2019 | -15.92% |
| Sep 30, 2019 | -12.71% |
| Jun 30, 2019 | -12.01% |
| Mar 31, 2019 | -11.78% |
| Dec 31, 2018 | -7.70% |
| Sep 30, 2018 | -5.12% |
| Jun 30, 2018 | -4.12% |
| Mar 31, 2018 | 364.19% |
| Dec 31, 2017 | 23.68% |
| Sep 30, 2017 | -18.01% |
| Jun 30, 2017 | 119.33% |
| Mar 31, 2017 | -13.91% |
| Dec 31, 2016 | -18.02% |
| Sep 30, 2016 | -16.51% |
| Jun 30, 2016 | -16.10% |
| Mar 31, 2016 | -10.93% |
| Dec 31, 2015 | -13.20% |
| Sep 30, 2015 | -63.62% |
| Jun 30, 2015 | -3.59% |
| Mar 31, 2015 | 194.40% |
| Dec 31, 2014 | -196.85% |
| Sep 30, 2014 | -3.51% |
| Jun 30, 2014 | -5.71% |
| Mar 31, 2014 | 220.48% |
| Dec 31, 2013 | -170.20% |
| Sep 30, 2013 | -7.24% |
| Jun 30, 2013 | -6.65% |
| Mar 31, 2013 | 281.55% |
| Dec 31, 2012 | -148.98% |
| Sep 30, 2012 | -2.95% |
| Jun 30, 2012 | 9.88% |
| Mar 31, 2012 | 2.53% |
| Dec 31, 2011 | -4.24% |
| Sep 30, 2011 | -3.75% |